《大行報告》花旗下調長實集團(01113.HK)目標價至47.1元 評級「中性」
花旗發表報告指,長實集團(01113.HK)上半年業績符合預期,派息持平。目標價由49元下調至47.1元,評級「中性」。不過,該行認為,集團以多元化的經常性收入作為後盾,每股派息可望穩步上升。
花旗指,在利率持續高企環境下,對香港住宅及寫字樓的前景持負面看法,但相信長實集團的經常性收入組合多元化,而且資產負債表穩健,應可推動股價取得較好的表現。該行相信,在預計經常性現金流入不斷增加的前提下,即使面臨相對波動的宏觀環境,集團仍能在2023至2025財年保持穩定的每股派息增長。
另外,花旗預計,集團可能會在中期業績公布後恢復股份回購,將成為短期催化劑。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.